Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul Alpern sold 6,003 shares of the stock in a transaction on Monday, October 5th. The shares were sold at an average price of $24.24, for a total value of $145,512.72. Following the completion of the transaction, the vice president directly owned 61,082 shares in the company, valued at approximately $1,480,627.68. This represents a 8.95% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Arteris Trading Down 2.4%
NASDAQ AIP opened at $22.84 on Friday. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03. The stock’s 50-day simple moving average is $24.44 and its two-hundred day simple moving average is $28.78. Arteris, Inc. has a twelve month low of $12.06 and a twelve month high of $50.26. The company has a market capitalization of $1.12 billion, a price-to-earnings ratio of -26.25 and a beta of 1.90.
Arteris (NASDAQ:AIP – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). The firm had revenue of $24.13 million during the quarter, compared to analysts’ expectations of $23.48 million. Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%. Research analysts forecast that Arteris, Inc. will post -0.68 EPS for the current fiscal year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on AIP shares. Oppenheimer started coverage on shares of Arteris in a report on Thursday, July 16th. They issued an “outperform” rating and a $40.00 price objective for the company. Craig Hallum began coverage on shares of Arteris in a research note on Monday, September 21st. They issued a “buy” rating and a $30.00 price target for the company. Weiss Ratings upgraded shares of Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 21st. Jefferies Financial Group raised Arteris from a “hold” rating to a “buy” rating and raised their price objective for the company from $35.00 to $50.00 in a research note on Friday, August 7th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $38.00 price objective on shares of Arteris in a report on Friday, August 7th. Six research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $39.43.
Get Our Latest Research Report on AIP
Arteris News Roundup
Here are the key news stories impacting Arteris this week:
- Positive Sentiment: Arteris received an additional $3.3 million from the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance initiative with BAE Systems and SiFive. The funding supports Arteris’ role in securing hardware-design supply chains and may improve its positioning in government and advanced-chip projects. Arteris funding article
- Positive Sentiment: The funding has renewed the “undervalued” investment narrative around Arteris, with investors focusing on potential long-term demand for semiconductor security and the company’s strategic partnerships. Oppenheimer also maintained its Buy rating, reinforcing the constructive analyst view. Arteris undervalued narrative article Oppenheimer rating article
- Neutral Sentiment: CEO K. Charles Janac, COO Laurent Moll and VP Paul Alpern reported multiple share sales. Several transactions were associated with tax-withholding obligations when equity awards vested, which limits their value as a signal of weakening management confidence. Laurent Moll insider sale
- Negative Sentiment: Bayview Legacy LLC sold 100,000 shares, worth approximately $2.38 million. Unlike the executive transactions, the filing did not identify tax withholding as the reason, potentially adding selling pressure and investor caution, although the holder still retains a sizable position. Bayview Legacy insider sale
- Negative Sentiment: Arteris’ latest quarterly EPS loss was wider than analysts expected, and the company remains unprofitable. That fundamental backdrop may be offsetting optimism about the new funding and analyst support.
About Arteris
Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.
The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.
See Also
- Five stocks we like better than Arteris
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
